Tuberculosis as a Major Global Health Problem in the 21st Century: A WHO Perspective

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Seminars in Respiratory and Critical Care Medicine

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2004-829520PMID 16088467
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Involving private health care providers in delivery of TB care: global strategy.

  2003cited by this paper
• What is the limit to case detection under the DOTS strategy for tuberculosis control?

  2003cited by this paper
• Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.

  2003cited by this paper
• Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.

  2003cited by this paper
• Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

  2003cited by this paper
• Decentralisation of tuberculosis services in an urban setting, Lilongwe, Malawi.

  2003cited by this paper
• Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda.

  2003cited by this paper
• Public-private mix for improved TB control in Ho Chi Minh City, Vietnam: an assessment of its impact on case detection.

  2003cited by this paper
• Evaluation of community contribution to tuberculosis control in Cape Town, South Africa.

  2003cited by this paper
• Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.

  2003cited by this paper
• The TB epidemic from 1992 to 2002.

  2003cited by this paper
• Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa.

  2003cited by this paper
• Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS

  2003cited by this paper
• Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi.

  2003cited by this paper
• Low access to a highly effective therapy: a challenge for international tuberculosis control.

  2002cited by this paper
• Evolution of WHO policies for tuberculosis control, 1948-2001.

  2002cited by this paper
• Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.

  2002cited by this paper
• Increasing transparency in partnerships for health – introducing the Green Light Committee

  2002cited by this paper
• Rebuttal: Evidence and uncertainties.

  2002cited by this paper
• TB and HIV: joint problems, joint solutions?

  2002cited by this paper
• Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru.

  2002cited by this paper
• Modeling the economic benefits of better TB vaccines.

  2001cited by this paper
• Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa

  2001cited by this paper
• Private practitioners and public health: weak links in tuberculosis control.

  2001cited by this paper
• Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).

  2001cited by this paper
• Public-private partnership in tuberculosis control: experience in Hyderabad, India.

  2001cited by this paper
• Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997.

  2001cited by this paper
• Preventing antiretroviral anarchy in sub-Saharan Africa.

  2001cited by this paper
• The Burden of Drug‐Resistant Tuberculosis and Mechanisms for Its Control

  2001cited by this paper
• Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  2001cited by this paper
• Responding to Market Failures in Tuberculosis Control

  2001cited by this paper
• Management of tuberculosis : a guide for low income countries

  2000cited by this paper
• Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries.

  2000cited by this paper
• Multidrug-resistant tuberculosis: long-term treatment outcome in the Netherlands.

  2000cited by this paper
• First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons.

  1999cited by this paper
• Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.

  1999cited by this paper
• Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications.

  1999cited by this paper
• Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

  1999cited by this paper
• Outcome of multi-drug-resistant tuberculosis in France: a nationwide case-control study.

  1999cited by this paper
• Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection.

  1999cited by this paper
• Studies on the treatment of tuberculosis undertaken by the British Medical Research Council Tuberculosis Units, 1946-1986, with relevant subsequent publications.

  1999cited by this paper
• Community contribution to tuberculosis care in countries with high tuberculosis prevalence: past, present and future.

  1999cited by this paper
• Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

  1998cited by this paper
• A cost analysis of the tuberculosis control programme in Elsies River, Cape Town

  1998cited by this paper
• Tuberculosis patients and practitioners in private clinics in India.

  1998cited by this paper
• TB Patients and Private-for-profit Health Care Providers in India

  1997cited by this paper
• Assessment of worldwide tuberculosis control. WHO Global Surveillance and Monitoring Project.

  1997cited by this paper
• Multidrug-resistant tuberculosis in Denmark 1993-1995.

  1997cited by this paper
• Successful management of a national tuberculosis programme under conditions of war.

  1997cited by this paper
• Tuberculosis and HIV: current status in Africa.

  1997cited by this paper
• Multidrug-resistant tuberculosis in patients without HIV infection.

  1995cited by this paper
• The International Union Against Tuberculosis and Lung Disease model National Tuberculosis Programmes.

  1995cited by this paper
• World development report 1993 : investing in health

  1993cited by this paper
• An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms.

  1992cited by this paper
• Treatment of tuberculosis by private general practitioners in India.

  1991cited by this paper
• The Mutual Assistance Programme of the IUATLD. Development, contribution and significance.

  1991cited by this paper
• Nosocomial epidemic of active tuberculosis among HIV-infected patients.

  1989cited by this paper
• Epidemiology of tuberculosis in the United States.

  1989cited by this paper
• The epidemiology of tuberculosis in the United States.

  1989cited by this paper
• Rifampin in initial treatment of pulmonary tuberculosis. A U.S. Public Health Service tuberculosis therapy trial.

  1971cited by this paper
• Die Aetiologie der Tuberkulose

  1932cited by this paper

• Development of the MTB/IC LAMP-MS Assay for Rapid Detection of Mycobacterium tuberculosis

  2025cites this paper
• Actualización en los patrones de infecciones pulmonares en pacientes inmunocompetentes

  2024cites this paper
• Pathogenesis of Human Immunodeficiency Virus and Mycobacterium tuberculosis Infection as Revealed by Transcriptome and Interactome Data

  2023cites this paper
• Pyridoxal phosphate, pyridoxamine phosphate, and folic acid based on ceRNA regulatory network as potential biomarkers for the diagnosis of pulmonary tuberculosis.

  2022cites this paper
• Identification of Hub Genes in Tuberculosis via Bioinformatics Analysis

  2021cites this paper
• Plasma metabolites Xanthine, 4-Pyridoxate, and d-glutamic acid as novel potential biomarkers for pulmonary tuberculosis.

  2019cites this paper
• Molecular detection of mutations in isolates of multidrug resistant tuberculosis and tuberculosis suspects by multiplex allele specific PCR.

  2018cites this paper
• Activity-based classification circumvents affinity prediction problems for pyrrolidine carboxamide inhibitors of InhA.

  2018cites this paper
• Bacterial Osmolyte System and Its Physiological Roles

  2017cites this paper
• Effectiveness of Planned Teaching Programme (PTP) on Knowledge regarding Tuberculosis and RNTCP among Student Nurses at selected Nursing Colleges of Hubli, Karnataka

  2016cites this paper
• TIP 45: Detoxification and Substance Abuse Treatment

  2016cites this paper
• Effect of spa treatment and speleotherapy in the treatment of chronic obstructive pulmonary disease – a pilot study

  2016cites this paper
• Effect of spa treatment and the epidemiology of tuberculosis in the Slovak republic in the year 201

  2016cites this paper
• Surveillance System Model for Pulmonary Tuberculosis Suspected in Pangkep Region, Indonesia

  2016cites this paper
• Evaluación de Genotype Mycobacterium Direct, nueva técnica genética de microbiología molecular en la detección de M. tuberculosis Complex y otras micobacterias atípicas en muestras de interés clínico

  2015cites this paper
• Treatment of chest wall tuberculosis with transdermal ultrasound-mediated drug delivery

  2015cites this paper
• NF-κB repressing factor downregulates basal expression and mycobacterium tuberculosis induced IP-10 and IL-8 synthesis via interference with NF-κB in monocytes

  2014cites this paper
• Approach to unequal hilum on chest X-ray

  2013cites this paper
• NF-κB Repressing Factor Inhibits Chemokine Synthesis by Peripheral Blood Mononuclear Cells and Alveolar Macrophages in Active Pulmonary Tuberculosis

  2013cites this paper
• Molecular detection of rifampicin resistance in multidrug-resistant Mycobacterium tuberculosis strains from North-Eastern Romania

  2013cites this paper
• Multicentric analysis of childhood tuberculosis in Turkey.

  2013cites this paper
• Novel magnetic resonance imaging scoring system for diagnosis of spinal tuberculosis: A preliminary report

  2013cites this paper
• Changing patterns and trends of multidrug-resistant tuberculosis at referral centre in Northern India: a 4-year experience.

  2013cites this paper
• Original Article

  2011cites this paper
• Increasing drug resistance of Mycobacterium tuberculosis in Sinaloa, Mexico, 1997-2005.

  2011cites this paper
• Infections of the lungs and pleura

  2010cites this paper
• Impact of Immigration on the Molecular Epidemiology of Tuberculosis in Rhode Island

  2010cites this paper
• Drug Resistance Assays for Mycobacterium tuberculosis

  2009cites this paper
• INVITED REVIEW SERIES: TUBERCULOSIS

  2009cites this paper
• Rekombinante bovin-humane Parainfluenzaviren Typ 3 als Impfvektoren gegen nicht-virale Antigene

  2008cites this paper
• Glycine Betaine Uptake by the ProXVWZ ABC Transporter Contributes to the Ability of Mycobacterium tuberculosis To Initiate Growth in Human Macrophages

  2008cites this paper
• Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.

  2008cites this paper
• Management and outcomes of suspected pulmonary tuberculosis in a resource-poor setting

  2008cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL CENTRO DE BIOTECNOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM BIOLOGIA CELULAR E MOLECULAR

  2008cites this paper
• Topliss Method in the Optimization of Salicylic Acid Derivatives as Potential Antimycobacterial Agents

  2008cites this paper
• Knowledge of tuberculosis and its management practices among medical interns in a resource-poor setting: implications for disease control in sub-Saharan Africa

  2007cites this paper
• Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis.

  2007cites this paper
• Critical evaluation of the Global DOTS Expansion Plan.

  2007cites this paper
• Building political commitment in Peru for TB control through expansion of the DOTS strategy

  2007cites this paper
• Development of a Simple High-Throughput Screening Protocol Based on Biosynthetic Activity of Mycobacterium tuberculosis Glutamine Synthetase for the Identification of Novel Inhibitors

  2006cites this paper
• Potential Tuberculostatic Agent: Micelle‐forming Pyrazinamide Prodrug

  2006cites this paper
• Genetically Determined Susceptibility to Tuberculosis in Mice Causally Involves Accelerated and Enhanced Recruitment of Granulocytes

  2006cites this paper
• Reviving an old idea: can artificial pneumothorax play a role in the modern management of tuberculosis?

  2006cites this paper
• A Clinical Review of 40 Cases With Tuberculous Spondylitis in Adults

  2006cites this paper
• The burden of disease, economic costs and clinical consequences of tuberculosis in the Philippines.

  2005cites this paper
• Interim Report of Task Force 5 Working Group on Tuberculosis

  2004cites this paper